Deerfield Management Company »

Biosante Pharmaceuticals shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $350k 6.3k 55.14
2014-09-30 $17M 607k 28.28
2014-06-30 $21M 607k 34.44
2014-03-31 $12M 372k 31.35

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Biosante Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Global Alpha Capital Management
William Blair Investment Management
Kennedy Capital Management
Jpmorgan Chase & Co
Thompson, Siegel, & Walmsley
Citadel Advisors
Charles Schwab Investment Management
Brandywine Global Investment Management
Bank of New York Mellon
Russell Investments
Assenagon Asset Management
Principal Financial Group
WEDGE Capital Management L

View all funds holding Biosante Pharmaceuticals